{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:24Z","timestamp":1792787904980,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Joint Special Project of the Guangxi Natural Science Foundation","award":["Grant No. 2025GXNSFHA069065"],"award-info":[{"award-number":["Grant No. 2025GXNSFHA069065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Uremic tumoral calcinosis (UTC) is a relatively rare but challenging complication in dialysis patients, characterized by abnormal calcium salt deposition. Parathyroidectomy (PTX) is a commonly used treatment; however, some patients experience limited postoperative symptom improvement, suggesting potential factors that affect PTX efficacy. This study aims to investigate the mechanisms underlying suboptimal remission of UTC after PTX to optimize treatment strategies and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We report a case of a maintenance hemodialysis patient whose UTC worsened after PTX. Following discontinuation of active vitamin D and intensified phosphorus management, the patient\u2019s calcium-phosphorus product significantly decreased, accompanied by marked regression of calcified lesions. To further explore possible mechanisms, we reviewed and analyzed previous literature on PTX treatment for UTC and compared our case with related reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings demonstrate considerable individual variability in PTX efficacy for UTC treatment, with calcium-phosphorus product (Ca\u00d7P) levels playing a critical role in patient prognosis. This study suggests that calcium-phosphorus metabolism may be a key factor influencing PTX outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the importance of controlling the calcium-phosphorus product in treating UTC.Postoperative management should focus on optimizing calcium-phosphorus metabolism, with particular attention to individualized phosphorus control strategies and appropriate use of active vitamin D.These approaches are crucial for enhancing PTX efficacy and improving long-term patient prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04507-3","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T09:15:04Z","timestamp":1765012504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Parathyroidectomy in the treatment of uremic tumoral calcinosis: a 9-year case report and meta-analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Haiting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingman","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"issue":"9","key":"4507_CR1","first-page":"2443","volume":"35","author":"YP Chou","year":"2022","unstructured":"Chou YP, Hsieh YK, Wu CL. Uremic Tumoral Calcinosis J Nephrol. 2022;35(9):2443\u20134.","journal-title":"Uremic Tumoral Calcinosis J Nephrol"},{"issue":"2","key":"4507_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5301\/JN.2011.6366","volume":"24","author":"VM Brandenburg","year":"2011","unstructured":"Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol. 2011;24(2):142\u20138.","journal-title":"J Nephrol"},{"issue":"6","key":"4507_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1159\/000506115","volume":"49","author":"G Ke","year":"2020","unstructured":"Ke G, Li S, Cui Y, Chen X, Che H, Dou C, et al. Treatment of uremic tumoral calcinosis in maintenance Hemodialysis patients. Blood Purif. 2020;49(6):658\u201364.","journal-title":"Blood Purif"},{"issue":"5","key":"4507_CR4","doi-asserted-by":"publisher","first-page":"100238","DOI":"10.1016\/j.clinme.2024.100238","volume":"24","author":"SH Tsai","year":"2024","unstructured":"Tsai SH, Kan WC, Jhen RN, Chang YM, Kao JL, Lai HY, et al. Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy. Clin Med. 2024;24(5):100238.","journal-title":"Clin Med"},{"issue":"3","key":"4507_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1542-4758.2012.00760.x","volume":"17","author":"S Sunder","year":"2013","unstructured":"Sunder S, Verma H, Venkataramanan K. Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic Hemodialysis patient. Hemodial Int Int Symp Home Hemodial. 2013;17(3):458\u201362.","journal-title":"Hemodial Int Int Symp Home Hemodial"},{"issue":"5","key":"4507_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jbspin.2007.08.012","volume":"75","author":"M Younes","year":"2008","unstructured":"Younes M, Belghali S, Zrour-Hassen S, B\u00e9jia I, Touzi M, Bergaoui N. Complete reversal of tumoral calcinosis after subtotal parathyroidectomy in a Hemodialysis patient. Joint Bone Spine. 2008;75(5):606\u20139.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"4507_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12882-023-03107-3","volume":"24","author":"J Li","year":"2023","unstructured":"Li J, Li X, Dong X, Ma L, Guo Z, Chen X. Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports. BMC Nephrol. 2023;24(1):55.","journal-title":"BMC Nephrol"},{"issue":"11","key":"4507_CR8","first-page":"860","volume":"59","author":"M Xiong","year":"2020","unstructured":"Xiong M, Wang J, Li XD, Yu YW, Zhang L. [Clinical characteristics of 10 patients with uremic tumoral calcinosis]. Zhonghua Nei Ke Za Zhi. 2020;59(11):860\u20135.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"4","key":"4507_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1086\/508069","volume":"79","author":"O Topaz","year":"2006","unstructured":"Topaz O, Indelman M, Chefetz I, Geiger D, Metzker A, Altschuler Y, et al. A deleterious mutation in SAMD9 causes normophosphatemic Familial tumoral calcinosis. Am J Hum Genet. 2006;79(4):759\u201364.","journal-title":"Am J Hum Genet"},{"key":"4507_CR10","unstructured":"Sottini L, Veniero P, De Gaetano A, Olivi L, Brunori G. [Hyperphosphatemic pseudotumoral calcinosis due to FGF23 mutation with secondary amyloidosis]. Giornale Italiano Di nefrologia: organo ufficiale Della societa Italiana Di nefrologia 2022; 39(4)."},{"issue":"9","key":"4507_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.12998\/wjcc.v2.i9.409","volume":"2","author":"I Fathi","year":"2014","unstructured":"Fathi I, Sakr M. Review of tumoral calcinosis: A rare clinico-pathological entity. World J Clin Cases. 2014;2(9):409\u201314.","journal-title":"World J Clin Cases"},{"issue":"1","key":"4507_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13256-017-1474-1","volume":"11","author":"R Guo","year":"2017","unstructured":"Guo R, Kurata T, Kondo T, Imanishi T, Mizuno T, Sakakibara T, et al. Tumoral calcinosis in the cervical spine: a case report and review of the literature. J Med Case Rep. 2017;11(1):304.","journal-title":"J Med Case Rep"},{"issue":"1","key":"4507_CR13","first-page":"119","volume":"33","author":"J Hamada","year":"2006","unstructured":"Hamada J, Tamai K, Ono W, Saotome K. Uremic tumoral calcinosis in Hemodialysis patients: clinicopathological findings and identification of calcific deposits. J Rhuematol. 2006;33(1):119\u201326.","journal-title":"J Rhuematol"},{"issue":"11","key":"4507_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2169\/internalmedicine.47.1051","volume":"47","author":"H Komaba","year":"2008","unstructured":"Komaba H, Tanaka M, Fukagawa M. Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Intern Med (Tokyo Japan). 2008;47(11):989\u201394.","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"12","key":"4507_CR15","first-page":"159","volume":"21","author":"M Mizobuchi","year":"2011","unstructured":"Mizobuchi M, Nakazawa A, Akizawa T. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD]. Clin Calcium. 2011;21(12):159\u201366.","journal-title":"Clin Calcium"},{"key":"4507_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12882-015-0103-8","volume":"16","author":"D Shang","year":"2015","unstructured":"Shang D, Xie Q, Ge X, Yan H, Tian J, Kuang D, et al. Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal Dialysis patients. BMC Nephrol. 2015;16:107.","journal-title":"BMC Nephrol"},{"key":"4507_CR17","doi-asserted-by":"crossref","unstructured":"Butman MP, Goodman W. Worsening of soft tissue calcifications in a hemodialysis patient following parathyroidectomy. Hemodialysis international International Symposium on Home Hemodialysis. 2004;8(2):130\u2013138.","DOI":"10.1111\/j.1492-7535.2004.01086.x"},{"issue":"10","key":"4507_CR18","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.mayocp.2016.06.025","volume":"91","author":"JT McCarthy","year":"2016","unstructured":"McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, et al. Survival, risk Factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016;91(10):1384\u201394.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"4507_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1159\/000332221","volume":"34","author":"EA Ross","year":"2011","unstructured":"Ross EA. Evolution of treatment strategies for calciphylaxis. Am J Nephrol. 2011;34(5):460\u20137.","journal-title":"Am J Nephrol"},{"issue":"2","key":"4507_CR20","first-page":"E34","volume":"21","author":"K Lindhard","year":"2017","unstructured":"Lindhard K, Broberg B, Groenberg H, Post Hansen H. Treatment of a soft tissue calcification in a patient receiving peritoneal Dialysis. Hemodial Int Int Symp Home Hemodial. 2017;21(2):E34\u20139.","journal-title":"Hemodial Int Int Symp Home Hemodial"},{"issue":"12","key":"4507_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2169\/internalmedicine.56.8145","volume":"56","author":"H Watanabe","year":"2017","unstructured":"Watanabe H, Koda R, Iino N, Narita I. Uremic tumoral calcinosis resolved by improvements in Hyperphosphatemia. Internal medicine. (Tokyo Japan). 2017;56(12):1605\u20136.","journal-title":"(Tokyo Japan)"},{"issue":"4","key":"4507_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.krcp.2014.09.002","volume":"33","author":"Y Kim","year":"2014","unstructured":"Kim Y, Hwang E, Park S. Resolution of uremic tumoral calcinosis in a patient on peritoneal Dialysis with long-term low-calcium dialysate treatment. Kidney Res Clin Pract. 2014;33(4):226\u20138.","journal-title":"Kidney Res Clin Pract"},{"key":"4507_CR23","doi-asserted-by":"crossref","unstructured":"Yeh H, Yeh H, Chiang CC, Yen JC, Wang IK, Liu SH et al. Hungry bone syndrome in peritoneal Dialysis patients after parathyroid surgery. Endocr Connections 2023; 12(10).","DOI":"10.1530\/EC-23-0107"},{"key":"4507_CR24","unstructured":"Cartwright C, Anastasopoulou C. Hungry bone syndrome. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.: StatPearls Publishing. Copyright \u00a9 2025. StatPearls Publishing LLC.; 2025."},{"issue":"4","key":"4507_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3747\/pdi.2009.00250","volume":"31","author":"HY Chu","year":"2011","unstructured":"Chu HY, Chu P, Lin YF, Chou HK, Lin SH. Uremic tumoral calcinosis in patients on peritoneal dialysis: clinical, radiologic, and laboratory features. Perit Dialysis International: J Int Soc Perit Dialysis. 2011;31(4):430\u20139.","journal-title":"Perit Dialysis International: J Int Soc Perit Dialysis"},{"issue":"1","key":"4507_CR26","doi-asserted-by":"publisher","first-page":"2516207","DOI":"10.1080\/0886022X.2025.2516207","volume":"47","author":"S Lu","year":"2025","unstructured":"Lu S, Zeng M, Li F, Ouyang C, Wu J, Hu J, et al. Treatment effects of human amnion-derived mesenchymal stem cells for skin lesions and metastatic pulmonary calcification in calciphylaxis patients - case series and literature review. Ren Fail. 2025;47(1):2516207.","journal-title":"Ren Fail"},{"issue":"1","key":"4507_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12893-019-0603-8","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Zeng M, Yang G, Huang Y, Wu B, Guo J, et al. Effects of parathyroidectomy on tumoral calcinosis in uremic patients with secondary hyperparathyroidism. BMC Surg. 2019;19(1):133.","journal-title":"BMC Surg"},{"key":"4507_CR28","doi-asserted-by":"crossref","unstructured":"Hernandez PM, Enos BD, Labarca TG, Vanderstelt AG. From the Old, the Best: Parathyroidectomy in the Management of Soft-Tissue and Vascular Calcification in Patients with Chronic Renal Disease. Case reports in nephrology. 2021;2021:9985308.","DOI":"10.1155\/2021\/9985308"},{"issue":"7","key":"4507_CR29","first-page":"349","volume":"22","author":"C Ben Taarit","year":"2001","unstructured":"Ben Taarit C, el Younsi F, Turki S, Mestiri M, Zlitni M, Ben Ma\u00efz H. [Tumorous calcinosis in hemodialysis: anatomo-clinical study Apropos of 3 cases]. Nephrologie. 2001;22(7):349\u201352.","journal-title":"Nephrologie"},{"issue":"3","key":"4507_CR30","first-page":"158","volume":"38","author":"C Geffriaud","year":"1992","unstructured":"Geffriaud C, Allinne E, Page B, Zingraff J, Jucquel JP, Bardin T, et al. Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: a case report. Clin Nephrol. 1992;38(3):158\u201361.","journal-title":"Clin Nephrol"},{"issue":"2","key":"4507_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/15701611113119990021","volume":"12","author":"M Rodriguez","year":"2014","unstructured":"Rodriguez M, Munoz-Castaneda JR, Almaden Y. Therapeutic use of calcitriol. Curr Vasc Pharmacol. 2014;12(2):294\u20139.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"4507_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s40001-024-01801-y","volume":"29","author":"D Gao","year":"2024","unstructured":"Gao D, Liu Y, Cui W, Lu X, Lou Y. A nomogram prediction model for hungry bone syndrome in Dialysis patients with secondary hyperparathyroidism after total parathyroidectomy. Eur J Med Res. 2024;29(1):208.","journal-title":"Eur J Med Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04507-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04507-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04507-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:14:23Z","timestamp":1768569263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04507-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4507"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04507-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was conducted in accordance with the Declaration of Helsinki. The need for ethical approval was waived by the institutional review board, as the report involves a retrospective analysis of anonymized clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of anonymized clinical information and images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}